(R)-(+)-1-Ethyl-2-pyrrolidinecarboxamide, 95+%, 100mg

Boc-Asp(OtBu)-OH, 98%, 10g

3-Methyl-1-butene (ca. 16.5% in N,N-Dimethylformamide, ca. 2mol/L)500mL

1-(9,10-Dihydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8(7H)-yl)-2,2,2-trifluoroethanone, 98%, 100g

Gly-Thr-OH, 1g

1-Phenylprop-2-yn-1-amine, 95+%, 5g

2-Aminobenzhydrazide, 95.0%, 100g

2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile, 97%, 1g

(2E)-1-(2,4-dimethylphenyl)-3-phenylprop-2-en-1-one, 95.0%, 10g

Ethyl 3-methylpyridazine-4-carboxylate, 95.0%, 5g

1-(2,6-Dimethoxypyridin-3-yl)methanamine dihydrochloride, 1g

L-Cysteic Acid>98.0%(T)25g

5-bromo-1-methyl-3-(trifluoromethyl)-1H-pyrazole, 95.0%, 5g